Intramuscular pentazocine versus diclofenac suppository and intramuscular pentazocine for postcaesarean section pain relief-A double blind RCT
Not Applicable
Not yet recruiting
- Conditions
- SurgeryPostcaesarean pain
- Registration Number
- PACTR201508001159254
- Lead Sponsor
- Dr OLATEJU Simeon Olugbade
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 136
Inclusion Criteria
ASA (American Society of Anesthesiologists¿ Classification) 1 and II status
Elective and emergency low segment caesarean section
Spinal anaesthesia
Exclusion Criteria
Refusal to participate in the study
Epigastic pain
Known peptic ulcer
Bleeding problem, excessive intraoperative blood loss (>1000mls)
Previous history of hypersensitivity reaction to NSAIDS, pentazocine, tramadoL
Excessive perioperative blood loss (>1000mls).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of pentazocine in postcaesarean pain management?
How does diclofenac suppository compare to intramuscular pentazocine for postoperative analgesia in cesarean sections?
Are there specific biomarkers that predict patient response to pentazocine-based postcaesarean pain relief?
What are the potential adverse events associated with pentazocine use in postcaesarean patients and how can they be managed?
How do pentazocine and diclofenac suppository combination therapies compare to standard-of-care analgesics for postcaesarean pain?